Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF) Announces Dividend of $0.48

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPF) announced a dividend on Wednesday, February 26th, NASDAQ Dividends reports. Stockholders of record on Friday, March 21st will be given a dividend of 0.48 per share on Thursday, May 1st. The ex-dividend date is Friday, March 21st. This is a positive change from Hikma Pharmaceuticals’s previous dividend of $0.47.

Hikma Pharmaceuticals Stock Performance

Shares of HKMPF traded down $1.74 during trading hours on Thursday, hitting $27.17. The stock had a trading volume of 821 shares, compared to its average volume of 2,203. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.98 and a current ratio of 1.66. The firm has a 50-day moving average price of $26.03 and a 200 day moving average price of $25.35. Hikma Pharmaceuticals has a fifty-two week low of $22.33 and a fifty-two week high of $28.92.

Analysts Set New Price Targets

Separately, Royal Bank of Canada upgraded shares of Hikma Pharmaceuticals from a “hold” rating to a “moderate buy” rating in a research report on Tuesday, December 10th.

Hikma Pharmaceuticals Company Profile

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.